Stockscreener 앱 받기
7.87
5.41%
-0.45
전일 마감가:
$8.32
열려 있는:
$8.17
하루 거래량:
287.79K
Relative Volume:
0.72
시가총액:
$203.06M
수익:
$34.26M
순이익/손실:
$-46.61M
주가수익비율:
-1.5191
EPS:
-5.1806
순현금흐름:
$-62.01M
1주 성능:
-10.16%
1개월 성능:
+21.08%
6개월 성능:
+94.32%
1년 성능:
+69.61%
1일 변동 폭
$7.84
$8.35
1주일 범위
$7.84
$8.96
52주 변동 폭
$3.53
$9.62
Precision Biosciences Inc Stock (DTIL) Company Profile
명칭
Precision Biosciences Inc
전화
919-314-5512
주소
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
7.87 | 214.67M | 34.26M | -46.61M | -62.01M | -5.1806 |
VRTX
Vertex Pharmaceuticals Inc
|
485.65 | 123.36B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.69 | 71.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
860.55 | 53.68B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
186.16 | 38.09B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
267.47 | 37.80B | 4.29B | 577.22M | 641.34M | 4.2086 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 개시 | Guggenheim | Buy |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-09 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 재개 | BTIG Research | Buy |
| 2020-04-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-05 | 개시 | Stifel | Buy |
| 2020-02-25 | 개시 | William Blair | Outperform |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | H.C. Wainwright | Buy |
| 2019-04-22 | 개시 | Barclays | Overweight |
| 2019-04-22 | 개시 | Goldman | Buy |
| 2019-04-22 | 개시 | JP Morgan | Overweight |
| 2019-04-22 | 개시 | Jefferies | Buy |
모두보기
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
Trading the Move, Not the Narrative: (DTIL) Edition - Stock Traders Daily
Precision BioSciences (DTIL) Proxy filing Summary - Quartr
Precision BioSciences announces grant of inducement awards - TipRanks
Precision BioSciences Grants Stock Units to New Employees Amid G - GuruFocus
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 10, 2026 - BioSpace
Precision BioSciences (DTIL) Grants Inducement Awards to New Hir - GuruFocus
Precision BioSciences (DTIL) Short Interest & Short Float | Updated Jul 2026 $DTIL - MarketBeat
Precision BioSciences, Inc. Actuals & Estimates (TRADEGATE:PBS0) - TradingView
DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus
H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength? - Yahoo Finance
Enterprise value to revenue forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView
Precision BioSciences Updates Investors with Latest Corporate Deck in July 2026 SEC 8-K Filing - Minichart
Precision BioSciences Advances Gene-Editing Programs in Hepatitis B - TipRanks
Precision BioSciences (NASDAQ: DTIL) shares HBV data, DMD trial timeline - Stock Titan
Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Index - marketscreener.com
Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Value Benchmark - marketscreener.com
Precision BioSciences added to Russell 2000 index By Investing.com - Investing.com Nigeria
Precision BioSciences added to Russell 2000 index - Investing.com
Precision BioSciences (DTIL) Joins Russell 2000 Index, Highlighting Growth Potential - GuruFocus
Index Expanding Market Visibility with Institutional Investors - Business Wire
Precision BioSciences Announces Inclusion in - Moomoo
Precision BioSciences, Inc.(NasdaqCM:DTIL) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Dynamic Index - marketscreener.com
Precision BioSciences, Inc. Actuals & Estimates (DUS:PBS0) - TradingView
Price to sales forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView
Precision BioSciences Inc (DTIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Price to earnings forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView
Precision BioSciences, Inc. Actuals & Estimates (NASDAQ:DTIL) - TradingView
Enterprise value to EBIT forward of Precision BioSciences, Inc. – LS:A400AS - TradingView
Enterprise value to revenue forward of Precision BioSciences, Inc. – LS:A400AS - TradingView
DTIL Forecast — Price Target — Prediction for 2027 - TradingView
Precision BioSciences earnings calendar and gene-editing focus, shares remain a small-cap biotech pl - AD HOC NEWS
Precision BioSciences Inc (DTIL) Institutional Confidence - TradingKey
Greenstone Biosciences And Intel Collaborate To Accelerate AI Driven Drug Discovery - BioPharma APAC
Precision BioSciences Inc (DTIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precision BioSciences Inc (DTIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precision BioSciences (DTIL) AGM 2026 Summary - Quartr
Precision BioSciences Inc (DTIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precision BioSciences Inc (DTIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Precision BioSciences Inc (DTIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Precision BioSciences Inc (DTIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precision BioSciences Inc (DTIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precision BioSciences Extends Term Loan Maturity to 2029 - TipRanks
Precision BioSciences Extends Term Loan Maturity to 2029 in Amendment With Banc of California - TradingView
Precision BiosciencesEnters First Amendment To Loan And Security Agreement With Banc Of CaliforniaSEC Filing - TradingView
Precision BioSciences (NASDAQ: DTIL) amends loan and extends term to 2029 - Stock Titan
Precision BioSciences, Inc. Amends Loan and Security Agreement with Banc of California - marketscreener.com
Oppenheimer Maintains Precision BioSciences(DTIL.US) With Buy Rating, Raises Target Price to $20 - Moomoo
DTIL Initiated Coverage by Oppenheimer -- Rating Set to Outperfo - GuruFocus
These stocks are gapping in today's session - ChartMill
Precision Biosciences Inc (DTIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precision Biosciences Inc 주식 (DTIL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Amoroso Michael | President and CEO |
Feb 18 '26 |
Sale |
3.84 |
20,559 |
78,947 |
243,392 |
| Kelly John Alexander | Chief Financial Officer |
Feb 17 '26 |
Option Exercise |
0.00 |
27,584 |
0 |
134,032 |
| Kelly John Alexander | Chief Financial Officer |
Feb 18 '26 |
Sale |
3.84 |
8,149 |
31,292 |
125,883 |
| Scimeca Dario | General Counsel and Secretary |
Feb 17 '26 |
Option Exercise |
0.00 |
16,667 |
0 |
61,382 |
| Scimeca Dario | General Counsel and Secretary |
Feb 18 '26 |
Sale |
3.84 |
4,925 |
18,912 |
56,457 |
| SMITH J. JEFFERSON | Chief Research Officer |
Feb 17 '26 |
Option Exercise |
0.00 |
16,667 |
0 |
126,851 |
| SMITH J. JEFFERSON | Chief Research Officer |
Feb 18 '26 |
Sale |
3.84 |
4,925 |
18,912 |
121,926 |
0.80%
2.11%
자본화:
|
볼륨(24시간):